Marksans Pharma informs about disclosure

24 Jul 2021 Evaluate

Pursuant to SEBI Circular No. SEBI/HO/ISD/CIR/P/2020/135 dated July 23, 2020, Marksans Pharma has informed that it has enclosed the reporting of violations related to Code of Conduct under SEBI (PIT) Regulations, 2015 by two Designated Persons of the Company in the prescribed formats.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

161.05 -2.05 (-1.26%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×